BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 36322427)

  • 21. Genomic origin, fragmentomics, and transcriptional properties of long cell-free DNA molecules in human plasma.
    Che H; Jiang P; Choy LYL; Cheng SH; Peng W; Chan RWY; Liu J; Zhou Q; Lam WKJ; Yu SCY; Lau SL; Leung TY; Wong J; Wong VW; Wong GLH; Chan SL; Chan KCA; Lo YMD
    Genome Res; 2024 Mar; 34(2):189-200. PubMed ID: 38408788
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adaptation of Oxford Nanopore technology for hepatitis C whole genome sequencing and identification of within-host viral variants.
    Riaz N; Leung P; Barton K; Smith MA; Carswell S; Bull R; Lloyd AR; Rodrigo C
    BMC Genomics; 2021 Mar; 22(1):148. PubMed ID: 33653280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative Analysis of PacBio and Oxford Nanopore Sequencing Technologies for Transcriptomic Landscape Identification of
    Udaondo Z; Sittikankaew K; Uengwetwanit T; Wongsurawat T; Sonthirod C; Jenjaroenpun P; Pootakham W; Karoonuthaisiri N; Nookaew I
    Life (Basel); 2021 Aug; 11(8):. PubMed ID: 34440606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implementation of Nanopore sequencing as a pragmatic workflow for copy number variant confirmation in the clinic.
    Greer SU; Botello J; Hongo D; Levy B; Shah P; Rabinowitz M; Miller DE; Im K; Kumar A
    J Transl Med; 2023 Jun; 21(1):378. PubMed ID: 37301971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Long and Short of Genome Sequencing: Using a Hybrid Sequencing Strategy to Sequence Oral Microbial Genomes.
    Heng NCK; Stanton JL
    Methods Mol Biol; 2023; 2588():75-89. PubMed ID: 36418683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fragment Size-Based Enrichment of Viral Sequences in Plasma Cell-Free DNA.
    Phung Q; Lin MJ; Xie H; Greninger AL
    J Mol Diagn; 2022 May; 24(5):476-484. PubMed ID: 35569878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characteristics, origin, and potential for cancer diagnostics of ultrashort plasma cell-free DNA.
    Hudecova I; Smith CG; Hänsel-Hertsch R; Chilamakuri CS; Morris JA; Vijayaraghavan A; Heider K; Chandrananda D; Cooper WN; Gale D; Garcia-Corbacho J; Pacey S; Baird RD; Rosenfeld N; Mouliere F
    Genome Res; 2022 Feb; 32(2):215-227. PubMed ID: 34930798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-throughput and affordable genome-wide methylation profiling of circulating cell-free DNA by methylated DNA sequencing (MeD-seq) of LpnPI digested fragments.
    Deger T; Boers RG; de Weerd V; Angus L; van der Put MMJ; Boers JB; Azmani Z; van IJcken WFJ; Grünhagen DJ; van Dessel LF; Lolkema MPJK; Verhoef C; Sleijfer S; Martens JWM; Gribnau J; Wilting SM
    Clin Epigenetics; 2021 Oct; 13(1):196. PubMed ID: 34670587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epigenetic analysis of cell-free DNA by fragmentomic profiling.
    Zhou Q; Kang G; Jiang P; Qiao R; Lam WKJ; Yu SCY; Ma ML; Ji L; Cheng SH; Gai W; Peng W; Shang H; Chan RWY; Chan SL; Wong GLH; Hiraki LT; Volpi S; Wong VWS; Wong J; Chiu RWK; Chan KCA; Lo YMD
    Proc Natl Acad Sci U S A; 2022 Nov; 119(44):e2209852119. PubMed ID: 36288287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cross-platform comparison of next-generation sequencing and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for detecting KRAS/NRAS/BRAF/PIK3CA mutations in cfDNA from metastatic colorectal cancer patients.
    Xu X; Huang F; Cao M; Chen X; Wang H; Jiang H; Yu Y; Shen M; Yang Y; Wang B; Liu T; Guo W
    J Clin Lab Anal; 2021 Sep; 35(9):e23818. PubMed ID: 34403504
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Size profile of cell-free DNA: A beacon guiding the practice and innovation of clinical testing.
    Shi J; Zhang R; Li J; Zhang R
    Theranostics; 2020; 10(11):4737-4748. PubMed ID: 32308746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single-molecule sequencing reveals a large population of long cell-free DNA molecules in maternal plasma.
    Yu SCY; Jiang P; Peng W; Cheng SH; Cheung YTT; Tse OYO; Shang H; Poon LC; Leung TY; Chan KCA; Chiu RWK; Lo YMD
    Proc Natl Acad Sci U S A; 2021 Dec; 118(50):. PubMed ID: 34873045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peripheral Blood Microbiome Analysis via Noninvasive Prenatal Testing Reveals the Complexity of Circulating Microbial Cell-Free DNA.
    Tong X; Yu X; Du Y; Su F; Liu Y; Li H; Liu Y; Mu K; Liu Q; Li H; Zhu J; Xu H; Xiao F; Li Y
    Microbiol Spectr; 2022 Jun; 10(3):e0041422. PubMed ID: 35608350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sequencing of individual barcoded cDNAs using Pacific Biosciences and Oxford Nanopore Technologies reveals platform-specific error patterns.
    Mikheenko A; Prjibelski AD; Joglekar A; Tilgner HU
    Genome Res; 2022 Apr; 32(4):726-737. PubMed ID: 35301264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypomethylation in HBV integration regions aids non-invasive surveillance to hepatocellular carcinoma by low-pass genome-wide bisulfite sequencing.
    Zhang H; Dong P; Guo S; Tao C; Chen W; Zhao W; Wang J; Cheung R; Villanueva A; Fan J; Ding H; Schrodi SJ; Zhang D; Zeng C
    BMC Med; 2020 Aug; 18(1):200. PubMed ID: 32741373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Shotgun metagenome data of a defined mock community using Oxford Nanopore, PacBio and Illumina technologies.
    Sevim V; Lee J; Egan R; Clum A; Hundley H; Lee J; Everroad RC; Detweiler AM; Bebout BM; Pett-Ridge J; Göker M; Murray AE; Lindemann SR; Klenk HP; O'Malley R; Zane M; Cheng JF; Copeland A; Daum C; Singer E; Woyke T
    Sci Data; 2019 Nov; 6(1):285. PubMed ID: 31772173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of long-read sequencing technologies in interrogating bacteria and fly genomes.
    Tvedte ES; Gasser M; Sparklin BC; Michalski J; Hjelmen CE; Johnston JS; Zhao X; Bromley R; Tallon LJ; Sadzewicz L; Rasko DA; Dunning Hotopp JC
    G3 (Bethesda); 2021 Jun; 11(6):. PubMed ID: 33768248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative analysis of PacBio and ONT RNA sequencing methods for Nemopilema Nomurai venom identification.
    Ma Y; Li J; Yu H; Teng L; Geng H; Li R; Xing R; Liu S; Li P
    Genomics; 2023 Nov; 115(6):110709. PubMed ID: 37739021
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multidimensional fragmentomic profiling of cell-free DNA released from patient-derived organoids.
    Kim J; Hong SP; Lee S; Lee W; Lee D; Kim R; Park YJ; Moon S; Park K; Cha B; Kim JI
    Hum Genomics; 2023 Oct; 17(1):96. PubMed ID: 37898819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of fragment sizes, copy number aberrations and 4-mer end motifs in cell-free DNA of hepatocellular carcinoma for enhanced liquid biopsy-based cancer detection.
    Jin C; Liu X; Zheng W; Su L; Liu Y; Guo X; Gu X; Li H; Xu B; Wang G; Yu J; Zhang Q; Bao D; Wan S; Xu F; Lai X; Liu J; Xing J
    Mol Oncol; 2021 Sep; 15(9):2377-2389. PubMed ID: 34133846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.